American Heart Journal
Volume 145, Issue 6 , Pages 986-992 , June 2003

Prediction of Recurrent Events by D-Dimer and Inflammatory Markers in Patients with Normal Cardiac Troponin I (PREDICT) study

  • Ian B.A Menown, MD

      Affiliations

    • Regional Medical Cardiology Centre, Royal Victoria Hospital, Belfast, Northern Ireland, UK
    • Corresponding Author InformationReprint requests: Dr Ian B.A. Menown, Regional Medical Cardiology Centre, Royal Victoria Hospital, Grosvenor Road, Belfast BT12 6BA, Northern Ireland, UK.
    • ,
  • Thomas P Mathew, MD

      Affiliations

    • Regional Medical Cardiology Centre, Royal Victoria Hospital, Belfast, Northern Ireland, UK
    • ,
  • Helen M Gracey, SRN

      Affiliations

    • Regional Medical Cardiology Centre, Royal Victoria Hospital, Belfast, Northern Ireland, UK
    • ,
  • G.Selby Nesbitt, BSc

      Affiliations

    • Regional Medical Cardiology Centre, Royal Victoria Hospital, Belfast, Northern Ireland, UK
    • ,
  • Pamela Murray, BSc

      Affiliations

    • Regional Medical Cardiology Centre, Royal Victoria Hospital, Belfast, Northern Ireland, UK
    • ,
  • Ian S Young, MD

      Affiliations

    • Regional Medical Cardiology Centre, Royal Victoria Hospital, Belfast, Northern Ireland, UK
    • ,
  • A.A.Jennifer Adgey, MD

      Affiliations

    • Regional Medical Cardiology Centre, Royal Victoria Hospital, Belfast, Northern Ireland, UK

References 

  1. Antman EM, Tanasijevic MJ, Thompson B, et al.  Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med. 1996;335:1342–1349
  2. Mathew TP, Menown IBA, Smith B, et al.  Diagnosis and risk stratification of patients with anginal pain and non-diagnostic electrocardiograms. Q J Med. 1999;92:565–571
  3. Morrow DA, Antman EM, Tanasijevic M, et al.  Cardiac troponin I for stratification of early outcomes and the efficacy of enoxaparin in unstable angina (a TIMI-11B substudy). J Am Coll Cardiol. 2000;36:1812–1817
  4. Heeschen C, Hamm CW, Goldmann B, et al.  Troponin concentrations for stratification of patients with acute coronary syndromes in relation to therapeutic efficacy of tirofiban. PRISM Study Investigators. Platelet Receptor Inhibition in Ischemic Syndrome Management. Lancet. 1999;354:1757–1762
  5. Myocardial infarction redefined—a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Eur Heart J 2000;21:1502-13
  6. Mathew TP, Menown IBA, Adgey AAJ. Optimising classification of acute myocardial infarction (from diagnosis to prognosis). Eur Heart J. 1999;20:1446–1448
  7. Ross R. Atherosclerosis—an inflammatory disease. N Engl J Med. 1999;340:115–126
  8. Ridker PM, Cushman M, Stampfer MJ, et al.  Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 1997;336:973–979
  9. Ridker PM, Rifai N, Stampfer MJ, et al.  Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation. 2000;101:1767–1772
  10. Ridker PM, Hennekens CH, Roitman-Johnson B, et al.  Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. Lancet. 1998;351:88–92
  11. Wallen NH, Held C, Rehnqvist N, et al.  Elevated serum intercellular adhesion molecule-1 and vascular adhesion molecule-1 among patients with stable angina pectoris who suffer cardiovascular death or non-fatal myocardial infarction. Eur Heart J. 1999;20:1039–1043
  12. Ridker PM, Buring JE, Rifai N. Soluble P-selectin and the risk of future cardiovascular events. Circulation. 2001;103:491–495
  13. Hwang SJ, Ballantyne CM, Sharrett AR, et al.  Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases (the Atherosclerosis Risk In Communities (ARIC) study). Circulation. 1997;96:4219–4225
  14. Montalescot G, Collet JP, Choussat R, et al.  Fibrinogen as a risk factor for coronary heart disease. Eur Heart J. 1998;19(Suppl H):H11–H17
  15. Ma J, Hennekens CH, Ridker PM, et al.  A prospective study of fibrinogen and risk of myocardial infarction in the Physicians’ Health Study. J Am Coll Cardiol. 1999;33:1347–1352
  16. Danesh J, Whincup P, Walker M, et al.  Fibrin d-dimer and coronary heart disease (prospective study and meta-analysis). Circulation. 2001;103:2323–2327
  17. Mulvihill NT, Foley JB, Murphy R, et al.  Evidence of prolonged inflammation in unstable angina and non-Q wave myocardial infarction. J Am Coll Cardiol. 2000;36:1210–1216
  18. Mulvihill NT, Foley JB, Murphy RT, et al.  Risk stratification in unstable angina and non-Q wave myocardial infarction using soluble cell adhesion molecules. Heart. 2001;85:623–627
  19. O’Malley T, Ludlam CA, Riemermsa RA, et al.  Early increase in levels of soluble inter-cellular adhesion molecule-1 (sICAM-1) (potential risk factor for the acute coronary syndromes). Eur Heart J. 2001;22:1226–1234
  20. Blankenberg S, Rupprecht HJ, Bickel C, et al.  AtheroGene Investigators   Circulating cell adhesion molecules and death in patients with coronary artery disease. Circulation. 2001;104:1336–1342
  21. Hollander JE, Muttreja MR, Dalesandro MR, et al.  Risk stratification of emergency department patients with acute coronary syndromes using P-selectin. J Am Coll Cardiol. 1999;34:95–105
  22. Bayes-Genis A, Mateo J, Santalo M, et al.  d-dimer is an early diagnostic marker of coronary ischemia in patients with chest pain. Am Heart J. 2000;140:379–384
  23. Bhatia VK, Haskard DO. Markers of inflammation in unstable angina. Heart. 2001;85:603–604
  24. Malik IS, Haskard DO. Soluble adhesion molecules in ischaemic heart disease. Eur Heart J. 1999;20:990–991
  25. Newby LK. Cardiac marker testing (where should we focus?). Am Heart J. 2000;140:351–353
  26. de Ferranti S, Rifai N. C-reactive protein and cardiovascular disease (a review of risk prediction and interventions). Clin Chim Acta. 2002;317:1–15
  27. Best PJ, Gersh BJ. Cell adhesion molecules and inflammation in acute coronary syndromes (markers and emerging risk factors). Eur Heart J. 2001;22:1155–1159
  28. Moss AJ, Goldstein RE, Marder VJ, et al.  Thrombogenic factors and recurrent coronary events. Circulation. 1999;99:2517–2522
  29. de Lemos JA, Hennekens CH, Ridker PM. Plasma concentration of soluble vascular cell adhesion molecule-1 and subsequent cardiovascular risk. J Am Coll Cardiol. 2000;36:423–426
  30. Galvani M, Ferrini D, Ottani F, et al.  Soluble E-selectin is not a marker of unstable coronary plaque in serum of patients with ischemic heart disease. J Thromb Thrombolysis. 2000;9:53–60
  31. Ridker PM, Hennekens CH, Cerskus A, et al.  Plasma concentration of cross-linked fibrin degradation product (d-dimer) and the risk of future myocardial infarction among apparently healthy men. Circulation. 1994;90:2236–2240
  32. Morrow DA, Cannon CP, Rifai N, et al.  Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction (results from a randomized trial). JAMA. 2001;286:2405–2412
  33. Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). Available at: http://www.acc.org/clinical/guidelines/unstable/unstable.pdf
  34. Libby P, Ridker PM. Novel inflammatory markers of coronary risk (theory versus practice). Circulation. 1999;100:1148–1150
  35. Ridker PM, Rifai N, Clearfield M, et al.  Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. N Engl J Med. 2001;344:1959–1965

☆ Supported by a research grant from the Heart Trust Fund, Royal Victoria Hospital.

PII: S0002-8703(03)00169-8

doi: 10.1016/S0002-8703(03)00169-8

American Heart Journal
Volume 145, Issue 6 , Pages 986-992 , June 2003

Article Tools

* Image Usage & Resolution